JACLYN SCHAVONE: Open Payments
NPI 1407453921 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,472 in 124 payments from 20 companies in 2025. Trend: 2023 $4,060 · 2024 $4,257 · 2025 $3,472
Food & beverage: $3,329Education: $143
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $557 |
| GENZYME CORPORATION | 10 | $463 |
| Janssen Biotech, Inc. | 14 | $437 |
| Galderma Laboratories, L.P. | 7 | $336 |
| Regeneron Healthcare Solutions, Inc. | 7 | $307 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $279 |
| Novartis Pharmaceuticals Corporation | 10 | $166 |
| UCB, Inc. | 7 | $160 |
| Arcutis Biotherapeutics, Inc. | 14 | $142 |
| Amgen Inc. | 4 | $121 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, RINVOQ, ILUMYA, Bimzelx, Zoryve.
Industry payments across NC — which companies pay providers there.
